Clinical trial
Aldosterone and Vascular Disease in Diabetes Mellitus
NCT00214825 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00214825 |
|---|---|
| Title | Aldosterone and Vascular Disease in Diabetes Mellitus |
| Official title | Aldosterone and Vascular Disease in Diabetes Mellitus |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Endothelial Dysfunction, Albuminuria |
| Intervention type | Drug |
| Interventions | eplerenone, Hydrochlorothiazide |
| Enrollment | 46 |
| Start date | Aug 1, 2003 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: